Greg Tucker-Kellogg

8PUBLICATIONS
27CO-AUTHORS
Epigenetics (incl. genome methylation and epigenomics)Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsNeurology and neuromuscular diseasesSemi- and unsupervised learning
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Sep 20, 2024
Super-silencer perturbation by EZH2 and REST inhibition leads to large loss of chromatin interactions and reduction in cancer growth.

Ying Zhang, Kaijing Chen, Seng Chuan Tang

|Jan 11, 2024
Comments on "Social inequalities in treatment receipt for childhood cancers in Ireland: A population-based analysis".

Neil Barrett, Greg Tucker-Kellogg, Owen P Smith

|Jul 20, 2022
Deep learning for de-convolution of Smad2 versus Smad3 binding sites.

Jeremy W K Ng, Esther H Q Ong, Lisa Tucker-Kellogg

|Aug 04, 2021
TDP-43 mediates SREBF2-regulated gene expression required for oligodendrocyte myelination.

Wan Yun Ho, Jer-Cherng Chang, Kenneth Lim

|Oct 31, 2020
Loss of TDP-43 in astrocytes leads to motor deficits by triggering A1-like reactive phenotype and triglial dysfunction.

Audrey Yi Tyan Peng, Ira Agrawal, Wan Yun Ho

Pageof 2